The study analyzes the quantification of GnRH through morning blood tests as an indicator for CPP, along with alterations in LH levels, the rate of gonadal and sexual development, height, and the growth velocity change as key parameters for monitoring CPP progression. This evidence concerns the gene GNRH1 and central precocious puberty.